Articles by Noumaan Qureshi

Indian Pharmaceutical Innovation – Post TRIPS

It is the twentieth anniversary of the new patent act in January 2025. The post-patent (P20) era is a story of resilience, determination, and charting a course that set global ambitions, a story of finding opportunity in adversity. It is a story for case studies in business schools, in international studies, in global health efforts.


Violence Against Medics – Lessons to Draw from Private Hospitals

One interesting fact: most medical colleges and linked public hospitals in major cities were designed in the British era, with an open ward design. A medical administrator, tongue-in-cheek, put it succinctly: “When these hospitals were designed, nobody would have imagined that doctors will face violence”.

Time for design thinking in public healthcare delivery!


Rethinking Healthcare Communications for the Indian Context

Indian healthcare is sometimes an enigma: on one hand is the finest center of medical excellence, while on the other, public health issues still lag. Apart from the highest incidence of diabetes on the chronic side, and Tuberculosis on the infectious disease side, as per NFHS data, more than 50%…


72nd Republic Day: What’s the Road Ahead for Indian Pharma?

“We are getting too happy, for too little”: these words of a senior pharma journalist a decade back sound prophetic now. Consolidation, CRAMS, para IV filings and challenges to innovators, acquisitions, out-licensing, US and developed markets business growth – key themes a decade back – are now replaced with headwinds…



MENU